CHAPTER 1 INTRODUCTION

1.1. KEY BENEFITS
1.2. KEY MARKET SEGMENTS
1.3. KEY PLAYERS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top winning strategies
3.2.2. Top investment pockets
3.2.3. Top player positioning

3.3. MARKET DYNAMICS

3.3.1. Drivers

3.3.1.1. Increase in geriatric population
3.3.1.2. Technological advancements
3.3.1.3. Rise in prevalence of respiratory diseases
3.3.1.4. Growing demand for portable monitoring devices

3.3.2. Restraints

3.3.2.1. Lack of awareness in developing countries

3.3.3. Opportunities

3.3.3.1. Increase in healthcare expenditure in emerging economies
3.3.3.2. Proactive monitoring

CHAPTER 4 SMART PULSE OXIMETERS MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Key market trends
4.1.2. Growth factors and opportunities
4.1.3. Market size and forecast
4.1.4. Fingertip pulse oximeters

4.1.4.1. Market size and forecast by end user
4.1.4.2. Market size and forecast by region

4.1.5. Hand-held pulse oximeters

4.1.5.1. Market size and forecast by end user
4.1.5.2. Market size and forecast by region

4.1.6. Pediatric Pulse Oximeters

4.1.6.1. Market size and forecast by end user
4.1.6.2. Market size and forecast by region

4.1.7. Wrist-worn pulse oximeters

4.1.7.1. Market size and forecast by end user
4.1.7.2. Market size and forecast by region

CHAPTER 5 SMART PULSE OXIMETERS MARKET, BY REGION

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. NORTH AMERICA

5.2.1. Key market trends
5.2.2. Growth factors and opportunities
5.2.3. Market size and forecast by product
5.2.4. Market size and forecast by end user
5.2.5. Market size and forecast by country
5.2.6. U.S. market size and forecast
5.2.7. Canada market size and forecast
5.2.8. Mexico market size and forecast

5.3. EUROPE

5.3.1. Key market trends
5.3.2. Growth factors and opportunities
5.3.3. Market size and forecast by product
5.3.4. Market size and forecast by end user
5.3.5. Market size and forecast by country
5.3.6. Germany market size and forecast
5.3.7. France market size and forecast
5.3.8. UK market size and forecast
5.3.9. Italy market size and forecast
5.3.10. Spain market size and forecast
5.3.11. Russia market size and forecast
5.3.12. Rest of Europe market size and forecast

5.4. ASIA-PACIFIC

5.4.1. Key market trends
5.4.2. Growth factors and opportunities
5.4.3. Market size and forecast by product
5.4.4. Market size and forecast by end user
5.4.5. Market size and forecast by country
5.4.6. Japan market size and forecast
5.4.7. China market size and forecast
5.4.8. Australia market size and forecast
5.4.9. India market size and forecast
5.4.10. South Korea market size and forecast
5.4.11. Taiwan market size and forecast
5.4.12. Indonesia market size and forecast
5.4.13. Thailand market size and forecast
5.4.14. Rest of Asia-Pacific market size and forecast

5.5. LAMEA

5.5.1. Key market trends
5.5.2. Growth factors and opportunities
5.5.3. Market size and forecast by product
5.5.4. Market size and forecast by end user
5.5.5. Market size and forecast by country
5.5.6. Brazil market size and forecast
5.5.7. Turkey market size and forecast
5.5.8. Venezuela market size and forecast
5.5.9. Saudi Arabia market size and forecast
5.5.10. Republic of South Africa market size and forecast
5.5.11. Colombia market size and forecast
5.5.12. Argentina market size and forecast
5.5.13. Rest of LAMEA market size and forecast

CHAPTER 6 COMPANY PROFILES

6.1. CONTEC MEDICAL SYSTEMS CO., LTD.

6.1.1. Company overview
6.1.2. Operating business segments

6.2. GENERAL ELECTRIC COMPANY

6.2.1. Company overview
6.2.2. Operating business segments
6.2.3. Business performance

6.3. HALMA PLC

6.3.1. Company overview
6.3.2. Operating business segments
6.3.3. Business performance

6.4. KONINKLIJKE PHILIPS N.V.

6.4.1. Company Overview
6.4.2. Operating business segments
6.4.3. Business performance
6.4.4. Key strategic moves and developments

6.5. MASIMO CORPORATION

6.5.1. Company overview
6.5.2. Operating business segments
6.5.3. Business performance
6.5.4. Key strategic moves and developments

6.6. MEDTRONIC PLC

6.6.1. Company overview
6.6.2. Operating business segments
6.6.3. BUSINESS PERFORMANCE
6.6.4. Key strategic moves and developments

6.7. NONIN MEDICAL, INC.

6.7.1. Company overview
6.7.2. Operating business segments
6.7.3. Key strategic moves and developments

6.8. OMRON CORPORATION

6.8.1. Company overview
6.8.2. Operating business segments
6.8.3. Business performance

6.9. SMITHS GROUP PLC

6.9.1. Company overview
6.9.2. Operating business segments
6.9.3. Business performance